Monoclonal Antibody
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 May 2011) | Viewed by 57528
Special Issue Editor
2. Indian Institute of Technology Palakkad, Kerala 678623, India
Interests: immunology; immune homeostasis; immunotherapy; host-pathogen interaction
Special Issues, Collections and Topics in MDPI journals
Keywords
- design and engineering antibody
- therapy
- autoimmune diseases
- cancer
- B cells
- T cells
- cytokines
- co-stimulatory molecules
- preclinical evaluation
- experimental models
- immunogenecity
- transplantation
- dermatology
- infectious diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issues
- Antibody Conjugates in Pharmaceuticals (2 articles)
- Antibody-Drug Conjugates (ADC): 2021 in Pharmaceuticals (5 articles)
- Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma in Pharmaceuticals (5 articles)